Patents Assigned to Allero Therapeutics B.V.
  • Treatment of immune diseases by administration of antigen-specific formulations
    Patent number: 11918683
    Abstract: The present invention relates to the treatment of autoimmune and allergic diseases by oromucosal administration of a formulation consisting of an optimized combination of antigen, tolerizing agent and mucoadhesive carrier for each immune disease indication.
    Type: Grant
    Filed: December 1, 2022
    Date of Patent: March 5, 2024
    Assignee: Allero Therapeutics B.V.
    Inventors: Emil Richard George Pot, Cornelis Johannes Leenhouts, Poul Sörensen
  • Treatment of immune diseases by administration of antigen-specific formulations
    Patent number: 11547662
    Abstract: The present invention relates to the treatment of autoimmune and allergic diseases by oromucosal administration of a formulation consisting of an optimized combination of antigen, tolerizing agent and mucoadhesive carrier for each immune disease indication.
    Type: Grant
    Filed: October 25, 2018
    Date of Patent: January 10, 2023
    Assignee: Allero Therapeutics B.V.
    Inventors: Emil Richard George Pot, Cornelis Johannes Leenhouts, Poul Sörensen
  • TREATMENT OF IMMUNE DISEASES BY ADMINISTRATION OF ANTIGEN-SPECIFIC FORMULATIONS
    Publication number: 20210030664
    Abstract: The present invention relates to the treatment of autoimmune and allergic diseases by oromucosal administration of a formulation consisting of an optimized combination of antigen, tolerizing agent and mucoadhesive carrier for each immune disease indication.
    Type: Application
    Filed: October 25, 2018
    Publication date: February 4, 2021
    Applicant: Allero Therapeutics B.V.
    Inventors: Emil Richard George Pot, Cornelis Johannes Leenhouts, Poul Sörensen